Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
Acuitas said CureVac omitted its scientists ... within an ongoing lawsuit in Virginia federal court. In July 2023, Pfizer and BioNTech filed a complaint with the U.S. District Court in ...
Curevac N V Ord Regulatory News. Live 0A9E RNS. Regulatory News Articles for Curevac Nv Curevac Ord Shs ...
CureVac has accused Pfizer and BioNTech of infringing its patents, including the patents at issue in the Acuitas case, in an ongoing lawsuit in Virginia. The case is Acuitas Therapeutics Inc v.
Kaiser Permanente Entity Reports Breach Of Data For 13 Million: Kaiser Permanente, the Oakland-based health care conglomerate, is warning millions of customers that one of its divisions may have ...
COVID-19 patent fights continue as Arbutus, Genevant come after Pfizer and BioNTech in new lawsuit Back in 2022 ... Moderna has also been sued by CureVac and Alnylam, along with COVID vaccine ...
Moderna and CureVac have also issued legal proceedings ... to vigorously defend against these claims.” BioNTech said it was aware of the lawsuit and that it would not comment on “legal ...
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 ...